ABSTRACT
Embryonic stem cells (ESCs) are pluripotent cells with an indefinite replication potential and an ability to differentiate into a variety of cell lineages, holding a great promise for regenerative medicine and biological research. The genome and transcriptome of ESCs have been extensively examined in order to decipher their selfrenewal and differentiation mechanisms. Global transcriptional profiling allows the identification of genes expressed differentially or uniquely in ESCs and the elucidation of the molecular signatures. Comparative genomics and transcriptomics help to explore evolutionarily conserved and divergent transcriptional patterns and functional landscape of ESCs, and identify fundamental and species-specific mechanisms controlling the pluripotency. Chromosomal mapping of the transcriptome demonstrates the coexpression of neighboring genes along the chromosome and highlights their dynamic changes in response to ESC differentiation. Epigenetic analysis reveals methylation patterns and microRNA profiles unique to ESCs. In this article, various aspects of genomic and transcriptomic studies on ESCs are reviewed, and important findings regarding ESC selfrenewal and differentiation are highlighted and discussed.
INTRODUCTION
Embryonic stem cells (ESCs) are pluripotent cells with an indefinite replication potential and an ability to differentiate into a variety of cell lineages. Due to these unique properties, ESCs hold an important therapeutic potential in regenerative medicine, particularly for the treatment of many currently incurable injuries or diseases such as spinal cord injury, diabetes, hematological, neurodegenerative and cardiovascular diseases (1) (2) (3) (4) (5) (6) (7) . Moreover, recent evidence supports a long-standing notion that cancers are initiated and maintained by cancer stem cells that might have arisen from deregulated normal stem or progenitor cells (8) . ESC studies may thus help to identify the molecular triggers and potential cures for various cancers. ESC differentiation is regulated by factors similar to those controlling germ layer formation and cell type specification. ESCs can thus serve as a model system to understand mechanisms controlling cell growth and differentiation, as well as early-stage development of human embryos, tissues, and organs (9) (10) (11) (12) .
A thorough understanding of the molecular factors and mechanisms that control the self-renewal and differentiation of ESCs is essential for realizing their potential in medicine and science. The genome and transcriptome of ESCs have been studied extensively in recent years for identifying molecular mechanisms regulating ESC pluripotency. Genome-wide expressional profiling provides a basis to examine changes of genes and pathways in response to ESC differentiation. Comparative transcriptomics and genomics help to explore evolutionarily conserved and divergent transcriptional patterns and functional landscape of ESCs. Epigenetic analyses, proteomic studies, and microRNA surveys, as well as the application of new technologies such as chromatin immunoprecipitation have facilitated the discovery of regulatory mechanisms and deepened our understanding of the core properties of ESCs. Here, we review various aspects of genomic and transcriptomic studies in exploring self-renewal and differentiation properties of ESCs, with particular emphasis on human ESCs.
GENOME-WIDE EXPRESSION PROFILE
Genome-wide expressional profiling has been conducted on a variety of cell lines of ESCs using microarray, EST, SAGE, MPSS, and RT-PCR methods (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) . These studies have generated a large volume of data to characterize the ESC transcriptome and to examine the changes of genes and pathways in response to ESC differentiation.
Molecular Signature
Comparative analyses of ESC expression profiles have been important for defining the molecular signature (16) (17) (18) (19) (20) 27) . Some studies compared gene expression profiles in undifferentiated ESCs with those in differentiated cells, particularly the embryoid body (EB), which is the earliest stage of ESC differentiation in culture (21) (22) (23) (24) . Others compared transcript expression data of human ESCs (hESCs) with those of mouse ESCs (mESCs) (13, 16, 17, 20) . By studying ESTs, Brandenberger et al. obtained 148, 453 ESTs from undifferentiated hESCs and differentiated derivatives (21) . Over 32,000 unique transcripts were identified as being expressed in undifferentiated hESCs. Among them, 532 were significantly up-regulated and 140 were significantly downregulated. In studies using SAGE and MPSS methods, Richards et al. (19) and Miura et al. (23) identified 192 or 50 genes that were up-regulated in hESCs as compared with differentiated cells. Sharov et al. (25) , on the other hand, identified potential marker genes characterizing mESCs by EST frequency analysis. Wei and colleagues (13) compared gene expression between human and mouse ESCs, and showed that LIFR was highly expressed in mouse but not in human, CD9 was highly expressed in human but not in mouse, and FGF2 was highly expressed in human but FGF4 was abundant in mouse. Importantly, some genes were often found in different expression datasets, such as OCT4, SOX2, NANOG, REX-1, UTF1, TERT, ABCG2, NODAL, TDGF1, LEFTB, BEX1, GATA4, and members of signaling pathways like FGF, WNT and BMP. Those genes, expressed exclusively or predominantly in ESCs and important for maintaining the pluripotency, were considered to be molecular signatures of ESCs (16, 22, 28, 29) .
Among different expressional profile studies, the overlap is however small in the genes identified to be overexpressed in ESCs. For example, Invanoa et al. (15) and Ramalho-Santos et al. (14) independently identified more than 200 genes over-expressed in ESCs, but there are only six genes in common between the two gene lists, despite the fact that the two studies used identical microarray chips and the same cell types (30) (31) (32) . Among the studies by Sperger et al. (18) , Sato et al. (16) , and Bhattacharya et al. (22) , only seven genes were found to be shared out of a total of 2,226 genes. Genetic diversity among different cell lines, differences in cell culture conditions, and sampling issues may account for the differences among different gene expression data. There are also possible flaws in the methods employed for such comparative analysis. Efforts have been made to examine comparability of different hESC microarray studies and identify shared genes (14, 15, 33 (18) . This study indicates that comparing the lists of upregulated genes is methodologically flawed. In such a comparison, a gene at the intersection of three lists must pass a statistical test three independent times, and the subsequent intersection's p-value is the cube of the lists' pvalues, resulting in fewer genes found to be significant. By an integrated correlation analysis (34) , a large set of common genes (111 up-regulated and 95 down-regulated genes) was identified from the three data sets, despite of the different ways that the experiments were conducted (33). The results were confirmed by real time RT-PCR (33). The study demonstrates that combined analyses of multiple experiments with proper statistical methods are helpful in reaching coherent conclusions.
Regulatory Pathways
Differential expression of genes between undifferentiated and differentiated states of ESCs highlights the dynamic change of transcriptional programs or pathways in response to ESC differentiation. Among the differentially expressed genes are various components of signaling pathways and transcriptional regulators that play key roles in ESC self-renewal and differentiation. Signaling pathways that are implicated from the ESC expression data include LIF, FGF, WNT, and NODAL pathways. The LIF pathway, for example, is required for rodent ESC selfrenewal but not essential for human (35) (36) (37) (38) (39) (40) . Consistent with this pattern, gene expressional profiling by microarray, SAGE, MPSS, and EST showed no expression or under-expression of LIFR, IL6ST, and other components of LIF signaling in undifferentiated hESCs (18, 19, 21) . Microarray and EST data also show the expression of FGF2 and all four FGF receptor transcripts in hESCs, suggesting that hESCs are responsive to FGF signaling (18, 21) . Most WNT pathway genes are expressed in hESCs and EBs, while agonists and antagonists of this pathway show differential expression levels (21) . This expression pattern suggests that hESCs are competent to respond to WNT signaling and that shifts in the balance of agonists and antagonists occur as hESCs initiate differentiation (21) . Moreover, the coordinated expression of members of the NODAL pathway, including agonists and antagonists (e.g. TDFG1, CER-1), suggests that this signaling pathway is important and tightly controlled for self-renewal and differentiation of hESCs (21).
Novel Genes and Splicing Variants
Studies on the ESC transcriptome have identified a number of expressed sequences and genes with unknown functions, and a diversity of splicing variants. The lack of expressed sequence data from hESCs prompted Brandenberger et al. to adopt the EST approach for expression profiling (21) . Of the 32,764 unique transcripts identified, 16,990 (52%) were found not to match any UniGene cluster and 5,390 (16%) did not match any previously generated EST. Likewise, in a gene expression analysis using the MPSS method, Miura et al. estimated that approximately 25% of all detectable transcripts in hESCs were associated with unknown functions (23) . On the other hand, Sharov et al. (25) discovered approximately 1,000 putative genes previously not identified by clustering ESTs from mESCs and other tissues. Novel transcripts or genes identified by these studies represent potential novel markers of ESCs and possible new mechanisms controlling ESC self-renewal and differentiation.
Pritsker et al. conducted a genome-wide survey of alternative splicing in human and mouse ESCs, using combined computational and experimental methods (41) . EST sequences available from hESCs and mESCs were examined by sequence alignments. The computational analysis identified splicing variation in 413 (3.2%) of the genes expressed in mESCs and 1,163 (9.1%) of the genes expressed in hESCs. The results were confirmed by RT-PCR and sequencing. The study demonstrates that the frequency of alternative splicing is especially high in tissue-specific genes as compared to ubiquitous genes. Alternative splicing preferentially affects component genes of MAPK, WNT, apoptosis, cell cycle and other signaling pathways important to stem cells. Alternative splicing significantly increases the complexity of the ESC transcriptome, thus constituting an important aspect to address for a comprehensive characterization of ESCs.
COMPARATIVE TRANSCRIPTOMICS
Significant similarities exist among ESCs harvested from different species, yet major differences are also observed (29, 42). Important sequence elements in the genome, as well as important biological processes or pathways, are often evolutionarily conserved (43) (44) (45) . The observed conservation and variation among ESCs suggest that comparative genomics or transcriptomics analyses may help distinguish between universal and species-specific mechanisms controlling ESC pluripotency. The evolutionary conservation on the genomic structure of ESC-critical genes and on the transcriptional changes during ESC differentiation is emerging as a powerful predictor of molecular factors and pathways important for ESC self-renewal and differentiation (46, 47) .
Conserved and Divergent Functional Landscape
Sun et al. conducted a comparative transcriptomics study to examine a large set of functional categories and all transcription factors and growth factors (46) . Global transcriptional changes derived from all expressed genes in ESCs and EBs, instead of changes in differentially expressed individual genes, were examined for a high discriminating power in functional profiling. The study identified many conserved functional categories showing positive correlations in the transcriptional changes that occur upon ESC differentiation, which represent fundamental molecular mechanisms regulation ESC pluripotency. The conserved biological processes include those involved in development, such as cellular morphogenesis, embryonic development, and pattern specification, and those involved in cell cycle, signal transduction, apoptosis, and establishment or maintenance of chromatin architecture (46) . Transcriptional factors such as MYB, MYCN, NFYB, POLR3K, POU2F1, and UTF1, and growth factors such as GDF3, LEFTB, and TDFG1 also show conserved transcriptional changes in ESC differentiation. Conserved biological processes and pathways such as TGF-beta, WNT, NODAL, and integrinmediated signaling are known to be important for ESC pluripotency. Yet, other conserved biological processes, pathways, and transcription or growth factors bear no overt relationship to ESC self-renewal and differentiation, which may represent new mechanisms controlling the pluripotency (46) . On the other hand, many functional categories, transcriptional factors and growth factors were divergent, showing negative or no correlation in the expression patterns across species (46) . The divergent functional categories, such as the LIF pathway, are suggestive of species-specific mechanisms controlling ESC self-renewal and differentiation (46).
Conserved and Divergent Coexpression Patterns
Gene coexpression analysis provides a systemslevel context to evaluate transcriptional changes and network dynamics. Zhan and colleagues (unpublished) conducted a comparative study on gene coexpression from global networks to specific pathways for human and mouse ESCs. The analysis showed that coexpression networks of ESCs were scale-free and modular, containing a few highly connected genes (i.e. hub genes) that linked the rest of less connected genes to the system. Between human and mouse, the coexpression networks were highly divergent; the hub genes were mostly species-specific, and the overlap on dense areas between the networks was low. Tightly coexpressed gene complexes were identified from cell cycle, DNA replication, the OCT4/SOX2/NANOG directed network, and in TGF-beta, WNT, JAK/STAT, and ATK/PTEN pathways. The gene complexes were either conserved or divergent across species, suggestive of fundamental or species-specific mechanisms of tight genegene interactions in regulating ESC pluripotency. The results of this study support much of current knowledge of ESC-related pathways and biological processes, and provide clues of new signature genes and novel mechanisms controlling ESC development.
COMPARATIVE GENOMICS
Zhan and colleagues performed a comparative genomics study in combination with gene expression analysis on pathways critical for ESC self-renewal and differentiation (47) . Genes of these pathways were examined for their genomic conservation and variation in both coding and regulatory regions. On the regulatory regions including promoters and enhancers, transcriptional factor binding sites (TFBS) were further examined. The study indicates that only a small set of transcription factors are likely critical in maintaining ESC pluripotency. The LIF pathway is evolutionarily divergent from the genomic perspective as the pathway components such as LIFR, EHOX, ERAS and GP130 are not conserved on the gene and promoter structure (47) . EHOX, for example, is present in the mouse genome, but no ortholog is present in the human genome. The closest human paralogs of EHOX are quite divergent and more importantly not expressed in hESCs. Likewise, ERAS, which plays a critical role in rodent ESC self-renewal, exists as a pseudogene (i.e. HRAS or RASP) in human. The pseudogene shows a high divergence on the non-coding regulatory region and nonsense deletion mutations in the coding region, and is not expressed in hESCs (47) (48) (49) . These results underline the fact that LIF and LIF-mediated signaling are not crucial for maintaining pluripotency in hESCs, and human and mouse ESCs show differential requirement of LIF signaling (38) (39) (40) . The pathways directed by OCT4, SOX2, NANOG, FGF, and NODAL, on the other hand, are conserved in both gene and promoter structure. This study suggests that the conserved OCT4/SOX2 synergistic action is an important activation mechanism in the NANOG, LIF, FGF, and OCT4 directed pathways (47) . SOX2, FOXD3, and ESG1 may serve in a feedback loop in these pathways; these pathways regulate the expression of the feedback loop, which in turn regulates the OCT4/SOX2 synergistic activation of these pathways. The NODAL/TDFG1/CER-1 pathway is independent of the OCT4/SOX2 activation and not involved in the feedback regulation. No FGF response element (FRE) (50) is present in STAT3, NANOG, or NODAL pathway genes, and no STAT-like binding sites are present in FGF4. However, FRE is present on regulatory regions of FGF4, SOX2, FOXD3, and ESG1, suggesting a basis for FGF regulating these genes in a parallel pathway to maintain ESC self-renewal.
A list of OCT4, SOX2, and NANOG target genes has been determined by cross-species genomic analysis followed by chromatin immunoprecipitation and gene expression analysis (51) (52) (53) (54) . Genes that are activated by OCT4, SOX2, and NANOG in ESCs are mostly upregulated and important for ESC self-renewal (51, 52) . The activated genes include transcription factors STAT3, ZIC3, REST, and HESX1, as well as chromatin and histone modification factors SMARCAD1, MYST3, and SET. Genes that are repressed by OCT4, SOX2, and NANOG are mostly down-regulated and participate in embryo development (51, 52) . The repressed genes include HAND1, HOXB1, PAX6, and ISL1. NANOG binds to the promoter regions of OCT4 and SOX2, as well as to its own promoter region, and OCT4 and SOX2 jointly bind to NANOG, OCT4, and SOX2 (51, 52) . The subsequently formed self-regulatory loop may help to stabilize the expression levels of these genes, since the precise level of OCT4 is required to maintain ESC pluripotency (40, 51) . The transcription factors OCT4, SOX2, and NANOG hence form a core regulatory circuitry and play a key role in determining the fate of ESCs (51) . This regulatory circuitry is unique and has no counterpart in non-mammalian genomes (55).
Chickarmane et al. conducted a computational modeling on the OCT4/SOX2/NANOG-directed network to examine the transcriptional dynamics, self-regulation, and target gene regulation (55) . The modeling, based on the Shea-Ackers formalism (56), identified a bistable switch between self-renewal and differentiation in ESCs. The ESC box can be switched ON by such signals as WNT in human and mouse ESCs and LIF in mouse ESCs. Suppression of NANOG signaling molecules such as p53 turns the switch OFF. The bistable switch arises due to positive feedback loops formed by self-regulation of these genes. The model predicts that increasing the binding strength of NANOG to OCT4 and SOX2, or increasing the basal transcriptional rate of NANOG, leads to an irreversible bistable switch, in which the switch remains ON even when the activating signal is removed. Hence, ESCs can maintain self-renewal without further input signals. Such computational modeling furthers our understanding of important factors and their interplay on ESC pluripotency and facilitates manipulation of ESCs for directed differentiation.
CHROMOSOMAL MAP OF TRANSCRIPTOME
By examining the coexpression of neighboring genes along the chromosome, Li et al. (57) reported a chromosomal map of the hESC transcriptome. The distribution of coexpression domains on the genome is not random: they are significantly enriched in chromosomes 8, 11, 16, 17, 19 , and Y in hESCs, and 6, 11, 17, 19 and 20 in EBs. Coexpression domains are biologically significant, and some of them are particularly associated with functions important to ESCs (57) . Many chromosome domains show differential coexpression between ESCs and EBs. Some of the differentially coexpressed domains contain genes that are critical for ESC pluripotency, such as SOX15, STAT3, UTF1, TLE1, and OCT4. The SOX15 domain, for example, shows coexpression in ESCs but not in EBs, and contains cytokine TNFSF1, the ephrin gene EFNB3, and genes involved in transcriptional regulation (POLR2A, ZBTB4, TP53, and FXR2),. The observation of differential coexpression at chromosomal domains suggests that transcriptional regulation interacts with genomic structure and chromatin architecture in hESC differentiation. Genomic organization thus affects gene expression in hESCs and is important for regulating ESC pluripotency.
EPIGENETIC REGULATION
Emerging evidence suggests that transcriptional changes that are associated with ESC self-renewal and differentiation involve the action of unique epigenetic programs (42, (58) (59) (60) (61) (62) (63) (64) . Epigenetic mechanisms important to ESCs include processes such as DNA methylation, non-coding RNA-mediated regulation, and histone modifications.
DNA Methylation
DNA methylation is a general indicator of silenced genome regions and is essential for the establishment of chromatin structure during development (61) (62) (63) . Many ESCspecific genes have been examined for the epigenetic status, and correlations between ESC development and DNA methylation have been established (58) (59) (60) (64) (65) (66) (67) 
MicroRNAs
The critical role of microRNAs in ESCs was first revealed by the analysis of dicer-1, which cleaves double stranded RNA into small segments of approximately 22 nucleotides as an essential enzyme in microRNA biogenesis (68) (69) (70) (71) . Dicer-deficient ESCs, which can not generate microRNAs, were shown to be defective in ESC differentiation (72) . ESC-specific microRNAs have been identified from both human and mouse and shown to play a unique role in ESC self-renewal and early differentiation (73, 74) . These microRNAs are expressed only in undifferentiated ESCs, and the expression is significantly reduced as ESCs differentiate into EBs and becomes undetectable in adult organs (73, 74) . MicroRNAs preferably expressed in other tissues or organs are poorly or not expressed in ESCs (73, 74) . Many ESC-specific microRNAs have related sequences and are organized into various gene clusters (73, 74) . In human, for example, 36 microRNAs are identified as ESC-specific, and eight of them (miR-302b, miR-302b*, miR-302c, miR-302c*, miR302a, miR-302a*, miR-302d, and miR-367) are located within a 200-bp region on chromosome 4, while another four microRNAs (miR-371, miR-372, miR-373, and miR-373*) are mapped within a 1050-bp region on chromosome 19 (74) . Some ESC-specific microRNA genes are conserved across different mammalian genomes (73, 74) . The ESC-specific microRNA miR-301 has the homolog in not only mammals but also in Fugu (73) . Thus, ESCspecific microRNAs are involved in key and conserved molecular mechanisms in a diversity of organisms.
CONCLUDING REMARKS
The gene expression in ESCs is carefully regulated and cells either maintain the pluripotent state by self-renewal or undergo differentiation. The self-renewal is under the control of ESC-specific genes and by active repression of cell type-specific genes. The differentiation is initiated by activating cell type specific pathways and repressing self-renewal signals. Various genomic and transcriptomic studies have facilitated the discovery of regulatory mechanisms and deepened our understanding of the core molecular properties of ESCs. Nonetheless, great challenges remain ahead as we seek to comprehend the accumulating information from different aspects of ESC research. Integrated approaches are required in analyzing various kinds of 'omics' data to distill coherent conclusions. Sophisticated bioinformatics algorithms and software await development in order to address the complex patterns and massive data derived from ESC studies.
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